|
U.S. FDA Announces New Drug Safety Risk Communication Program
The U.S. Food and Drug Administration (FDA) has released a final guidance detailing new and current programs that convey drug safety information to the public as part of a larger drug safety initiative, the agency announced. This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives